Ides (0.50 mg/kg)    (DrugBank: IdeS)

1 disease
IDDisease name (Link within this page)Number of trials
64Thrombotic thrombocytopenic purpura1

64. Thrombotic thrombocytopenic purpura    [ 74 clinical trials,   76 drugs,   (DrugBank: 19 drugs),   15 drug target genes,   57 drug target pathways]
Searched query = "Thrombotic thrombocytopenic purpura", "TTP", "Upshaw-Schulman syndrome", "USS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 74 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02854059
(ClinicalTrials.gov)
September 201627/7/2016IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) PatientsA Phase II Pilot Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients With Low ADAMTS13 ActivityPurpura, Thrombotic ThrombocytopenicBiological: IdeS (0.25 mg/kg);Biological: IdeS (0.50 mg/kg)Hansa Biopharma ABUniversity College London HospitalsTerminated18 YearsN/AAll2Phase 2United Kingdom